Abstract
Current evidence indicates that factor VIII is a glycoprotein complex of two distinct proteins or polypeptide components, which circulates as polymers ranging in size from 800 000 to 20 × 106 daltons. Lack of synthesis of whole or part of this complex results in a bleeding diathesis. One protein (VIII:C) is controlled by an X-linked gene, the other (VIII:vWf) is inherited autosomally. The two major biological functions of this molecular complex are participation in coagulation and involvement in adhesion of platelets to damaged surfaces. Unlike most other proteins involved in coagulation, factor VIII is not a serine protease and its structure and amino acid composition is unknown.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
HOYER, L. W. (1981). The Factor VIII complex: structure and function. Blood, 58, 1
HOYER, L. W. (1976). Von Willebrand’s disease. In SPAET, E.H. (ed.). Progress in Hemostasis and Thrombosis. Vol. 3, p. 231. ( New York: Grune & Stratton )
HOWARD, M.A., MONTGOMERY, D.C., HARDISTY, R.M. (1974). Factor VIII-related antigen in platelets. Thromb. Res., 4, 617
ITALIAN WORKING GROUP. (1977). Spectrum of von Willebrand’s disease: A study of 100 cases. Br. J. Haematol., 35, 101
KOUTTS, J., HOWARD, M.A. and FIRKIN, B. G. (1979). Factor VIII physiology and pathology in man. In Progress in Hematology, Vol. XI, p. 115. ( New York: Grune & Stratton )
MONTGOMERY, R. R., HATHAWAY, W. E., JOHNSON, J., JACOBSON, L. and MUNTEAN, W. (1982). A variant of von Willebrand’s disease with abnormal expression of Factor VIII procoagulant activity. Blood, 60, 201
PICKERING, N. J., BRODY, J. I. and BARROT, T. (1981). Von Willebrand syndromes and mitral valve prolapse. Linked mesenchymal dysplasias. N. Engl. J. Med., 305, 131
RUGGERI, Z.M., MANNUCCI, P. M., LOMBARDI, R., FEDERKI, A.B. and ZIMMERMAN, T. S. (1982). Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP. Implications for pathophysiology and therapy of von Willebrand’s disease subtypes. Blood, 59, 1271
RUGGERI, Z.M., NILSSON, I.M., LOMBARDI, R., HOLMBERG, L. and ZIMMERMAN, 1. S. (1982). Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand’s disease (Type IIC). J. Clin. Invest., 70, 1124
TAKAHASHI, H., NAGAYAMA, R., HATTORI, A., IHZUMJ, T., TSOKADA, T. and SHIBATA, A. (1981). Von Willebrand disease associated with familial thrombocytopenia and increased ristocetin-induced platelet aggregation. Am. J. Hematol., 10, 89
VON WILLEBRAND, E. A. (1931). Über hereditäre pseudohämophilie. Acta Med. Scand., 76, 522
WEISS, H. J. (1975). Abnormalities of factor VIII and platelet aggregation - use of ristocetin in diagnosing the von Willebrand syndrome. Blood, 45, 403
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Firkin, B.G. (1984). Von Willebrand disease. In: The Platelet and its Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-8117-4_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-8117-4_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-8119-8
Online ISBN: 978-94-011-8117-4
eBook Packages: Springer Book Archive